4//SEC Filing
Worthington Mark 4
Accession 0001415889-24-004165
CIK 0001620463other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:01 PM ET
Size
5.7 KB
Accession
0001415889-24-004165
Insider Transaction Report
Form 4
Worthington Mark
General Counsel and CCO
Transactions
- Award
Stock Option (Right to Buy)
2024-02-14+220,000→ 220,000 totalExercise: $3.26Exp: 2034-02-13→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]Shares subject to the option shall be scheduled to vest monthly over a term of 48 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001861464
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:01 PM ET
- Size
- 5.7 KB